These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6395139)

  • 21. [Antigenic variability of E. coli K-12 recombinations in vivo].
    Intizarov MM; Orlovskii VI
    Veterinariia; 1972 Oct; 10():64-6. PubMed ID: 4575679
    [No Abstract]   [Full Text] [Related]  

  • 22. Synergistic effect of cefotaxime and normal human serum on bactericidal activity against urinary strains of Escherichia coli with capsular antigen K1.
    Franiczek R; Jankowski S
    Acta Microbiol Pol; 1993; 42(3-4):243-50. PubMed ID: 7516615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic characteristics of the stable protoplast type L-form of Escherichia coli W 1655 F+.
    Toshkov A; Ivanova E; Gumpert I; Ivanov B
    Acta Microbiol Bulg; 1980; 6():3-10. PubMed ID: 6803521
    [No Abstract]   [Full Text] [Related]  

  • 24. Permeabilization of E. coli K12 inner and outer membranes by bothropstoxin-I, A LYS49 phospholipase A2 from Bothrops jararacussu.
    Aragão EA; Chioato L; Ward RJ
    Toxicon; 2008 Mar; 51(4):538-46. PubMed ID: 18160090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosynthesis of K88 fimbriae in Escherichia coli: interaction of tip-subunit FaeC with the periplasmic chaperone FaeE and the outer membrane usher FaeD.
    Mol O; Oudhuis WC; Oud RP; Sijbrandi R; Luirink J; Harms N; Oudega B
    J Mol Microbiol Biotechnol; 2001 Jan; 3(1):135-42. PubMed ID: 11200226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of action of novel polyamines increasing the permeability of bacterial outer membrane.
    Yasuda K; Ohmizo C; Katsu T
    Int J Antimicrob Agents; 2004 Jul; 24(1):67-71. PubMed ID: 15225864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of quaternization on local anesthetic effects of trimecaine].
    Stankovicová T; Nemcek V; Stolc S
    Ceska Slov Farm; 1995 Oct; 44(5):265-7. PubMed ID: 8520924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunochemical study of Escherichia coli serogroup O20 antigens].
    Kovalenko EA; Zakharova IIa
    Mikrobiol Zh; 1972; 34(4):466-72. PubMed ID: 4576617
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of the membrane stabilizer ajmaline and the local anesthetic trimecaine on the pharmacologic effects of strophanthin in experiments in vivo and in vitro].
    Galenko-Iaroshevskiĭ PA; Lemkina SM; Kostin IaV
    Biull Eksp Biol Med; 1994 Jan; 117(1):59-61. PubMed ID: 8193333
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimicrobial activity of melanoidins against Escherichia coli is mediated by a membrane-damage mechanism.
    Rurián-Henares JA; Morales FJ
    J Agric Food Chem; 2008 Apr; 56(7):2357-62. PubMed ID: 18338864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Permeability of the membrane of the Escherichia coli envelope for ethidium bromide].
    Govorunov IG; Kosarev NV; Evtodienko IuV; Puchkov EO
    Mikrobiologiia; 1982; 51(5):731-4. PubMed ID: 6817038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaplasma marginale major surface protein 1a directs cell surface display of tick BM95 immunogenic peptides on Escherichia coli.
    Canales M; Almazán C; Pérez de la Lastra JM; de la Fuente J
    J Biotechnol; 2008 Jul; 135(4):326-32. PubMed ID: 18582976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Structure of the O-antigen side chains of Escherichia coli serotype 020].
    Vasil'ev VN; Zakharova IIa; Kovalenko EA
    Mikrobiol Zh (1978); 1980; 42(4):456-61. PubMed ID: 6997698
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mesocain and heart rhythm disturbances (author's transl)].
    Hurych J; Písa Z
    Cas Lek Cesk; 1976 Aug; 115(32):978-80. PubMed ID: 975163
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antiarhythmic effects of mesocain and possibilities of its preventive uses (author's transl)].
    Hammer J; Málek I; Spácil J; Stanĕk V; Smídek J
    Cas Lek Cesk; 1976 Aug; 115(32):990-2. PubMed ID: 975165
    [No Abstract]   [Full Text] [Related]  

  • 36. Toxicology of Mesocaine.
    Trcka V; Vanĕcek M; Smídek J
    Rev Czech Med; 1977; 23(2):69-76. PubMed ID: 407637
    [No Abstract]   [Full Text] [Related]  

  • 37. [Membrane-active properties of a preparation from a bacterial culture broth possessing autoregulation action].
    Vostroknutova GN; Kaprel'iants AS; Svetlichnyĭ VA; El'-Registan GI; Shevtsov VV
    Prikl Biokhim Mikrobiol; 1983; 19(4):547-51. PubMed ID: 6413971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microfluidic chip analysis of outer membrane proteins responsible for serological cross-reaction between three Gram-negative bacteria: Proteus morganii O34, Escherichia coli O111 and Salmonella Adelaide O35.
    Péterfi Z; Kustos I; Kilár F; Kocsis B
    J Chromatogr A; 2007 Jul; 1155(2):214-7. PubMed ID: 17362972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli.
    van der Kraan MI; van Marle J; Nazmi K; Groenink J; van 't Hof W; Veerman EC; Bolscher JG; Nieuw Amerongen AV
    Peptides; 2005 Sep; 26(9):1537-42. PubMed ID: 16112390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Escherichia coli as a biologically active ingredient of suppositories. Solid phase extraction and quantification in a double antibody ELISA.
    Barthold E; Bayer M; Maasch HJ
    Arzneimittelforschung; 1994 Jan; 44(1):102-8. PubMed ID: 8135872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.